Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)
Clinical trial NCT02279173 · COMPLETED
Trial details
- NCT number
- NCT02279173
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-10
- Primary completion
- 2018-08-30
- Enrollment
- 203
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.